Dose-Expansion Part of a Phase 1B Global Study of E7386 in Combination with Lenvatinib (Len) in Patients (Pts) with Hepatocellular Carcinoma (Hcc) and Other Solid Tumors Including Endometrial Cancer (Ec).
AuthID
P-017-VJX
P-017-VJX